# Royalty Pharma plc (RPRX): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/rprx for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Medical - Pharmaceuticals
- Exchange: NASDAQ · Trading currency: USD

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company was founded in 1996 and is based in New York, New York.

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $65.28 USD |
| Market Cap | $37.54B |
| P/E (TTM) | 12.43 |
| EPS (TTM) | $5.25 |
| 52-Week Range | $35.92 – $65.51 |
| Dividend Yield (TTM) | 1.42% |

## Dividend

| Metric | Value |
|---|---|
| Yield (TTM) | 1.42% |
| Annual Dividend (TTM) | $0.92 /share |
| Annual Dividend (Forward) | $0.94 /share |
| Frequency | Quarterly |
| Consecutive Growth Streak | 6 years |
| Growth CAGR 1Y / 3Y / 5Y / 10Y | 6.8% / 5.5% / 6.7% / — |
| Payout Ratio (EPS, TTM) | 52.3% |
| Payout Ratio (FCF, TTM) | 13.6% |
| Payout Ratio (EPS, forward dividend) | 54.0% |
| Payout Ratio (FCF, forward dividend) | 14.1% |

### Recent Payments

| Ex-Date | Amount | Pay Date |
|---|---|---|
| 2026-11-13 | $0.2350 | 2026-12-10 |
| 2026-08-14 | $0.2350 | 2026-09-10 |
| 2026-05-15 | $0.2350 | 2026-06-10 |
| 2026-02-20 | $0.2350 | 2026-03-10 |
| 2025-11-14 | $0.2200 | 2025-12-10 |
| 2025-08-15 | $0.2200 | 2025-09-10 |
| 2025-05-16 | $0.2200 | 2025-06-10 |
| 2025-02-21 | $0.2200 | 2025-03-10 |
| 2024-11-15 | $0.2100 | 2024-12-10 |
| 2024-08-16 | $0.2100 | 2024-09-13 |
| 2024-05-16 | $0.2100 | 2024-06-14 |
| 2024-02-15 | $0.2100 | 2024-03-15 |

Full history: https://www.dividenddata.com/stocks/rprx/dividend

## Frequently Asked Questions

### What does Royalty Pharma plc do?

Royalty Pharma plc (RPRX) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is RPRX's market cap?

Royalty Pharma plc (RPRX) has a market capitalization of approximately $37.54 billion, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does RPRX pay a dividend?

Yes, Royalty Pharma plc (RPRX) pays a dividend quarterly, with a trailing-twelve-month yield of 1.42%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

### How often does RPRX pay dividends?

Royalty Pharma plc pays dividends quarterly. The forward annual rate is $0.94 per share at the current declared cadence. Each ex-dividend date, record date, and payment date is listed in the dividend history table on this page.

### What is RPRX's payout ratio?

Royalty Pharma plc's payout ratio is the percentage of earnings (and free cash flow) returned to shareholders as dividends. Current EPS and FCF coverage are shown in the payout cards above, with green / amber / red coloring indicating sustainability.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/rprx
- Dividend history & safety: https://www.dividenddata.com/stocks/rprx/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/rprx/earnings
- Financial statements: https://www.dividenddata.com/stocks/rprx/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/rprx/valuation
- Peer comparison: https://www.dividenddata.com/stocks/rprx/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.